Cresco clients Snoozeal are among a handful of innovative projects to benefit from a £9million funding boost through the government’s Digital Health Technology Catalyst.
All recipients of the £9m are innovative digital technology projects which address key challenges in healthcare, with the ultimate aim of benefiting patients.
The catalyst, which is delivered by UK Research and Innovation, aims to accelerate the development of digital health innovation, under the Industrial Strategy Challenge Fund, to ensure the UK remains a leader in innovative healthcare.
Snoozeal, who are based in Leicester and work with the University of Loughborough, has developed a device to treat obstructive sleep apnoea.
Sleep apnoea is a condition where the muscles and soft tissues in the throat relax and collapse, blocking the airways for 10 seconds or more during sleep, which can cause long-term health problems.
Snoozeal device treats sleep apnoea
However, Snoozeal’s innovative device contracts muscle at the rear of the tongue through a 20-minute daily toning regime of mild electric pulses.
The device aims to be connected to an intelligent platform to collect biosensor data of tongue tone, which will be classified by machine learning and AI-based to deliver personalised treatment regimes.
Other projects to benefit from the funding boost include recipients who are using new technologies to address urgent healthcare priorities, by developing the likes of machine learning and hand-held devices to improve the targeting of clinical interventions, to portable brain imaging technology which helps identify patients’ personalised risk of developing dementia.
“From using AI-driven voice technology to assess patient’s health before seeing a doctor, to hand-held devices which observe health status and alert clinicians to treat high-risk patients, we are taking steps to ensure people are healthier for longer while saving the NHS money,” said Science and Innovation Minister Chris Skidmore.
Showcasing the best of British know-how
“These advances in technology, across the UK, demonstrate our modern Industrial Strategy in action by harnessing the power of innovation to help meet the needs of an ageing society, and creating the high skilled jobs of the future.”
Ian Campbell, Interim Executive Chair, Innovate UK, for UK Research and Innovation, added: “The UK is a world leader in health innovation and the projects for which we have announced funding showcase the very best of British know-how.
“Using breakthrough technologies such as AI and machine learning and deploying apps and hand-held devices, outcomes for patients can be immeasurably improved.
“Supporting these innovations is a key element of the government’s Industrial Strategy and will create the industries and jobs of tomorrow.”
The Digital Health Technology Catalyst is a £35million fund, being run over four years and is funded through the Industrial Strategy Challenge Fund.
Paul is a specialist in procurement and leads the Cresco tendering team. Paul has previously been supply chain manager for blue chip companies, including National Grid and Balfour Beatty.